Skip to main navigation Skip to search Skip to main content

Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial (Nature Medicine, (2025), 31, 6, (1994-2003), 10.1038/s41591-025-03627-5)

Frank J. Lowery, Stephanie L. Goff*, Billel Gasmi, Maria R. Parkhurst, Nivedita M. Ratnam, Hyunmi K. Halas, Thomas E. Shelton, Michelle M. Langhan, Aarushi Bhasin, Aaron J. Dinerman, Victoria Dulemba, Ian S. Goldlust, Alexandra M. Gustafson, Abraham A. Hakim, Kyle J. Hitscherich, Lisa M. Kenney, Lior Levy, Juliette G. Rault-Wang, Alakesh Bera, Satyajit RayCourtney D. Seavey, Chuong D. Hoang, Jonathan M. Hernandez, Jared J. Gartner, Sivasish Sindiri, Todd D. Prickett, Lori S. McIntyre, Sri Krishna, Paul F. Robbins, Nicholas D. Klemen, Mei Li M. Kwong, James C. Yang, Steven A. Rosenberg*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-03627-5, published online 1 April 2025. In the version of the article initially published, the footnote descriptions in the Fig. 1 caption read “aAs described in ref. 14. bIncluding a single patient described in reference 15. cBreast and ovarian cohorts described in refs. 16,45” and have now been amended to “aBreast and ovarian cohorts described in refs. 16,45. bAs described in ref. 14. cIncluding a single patient described in reference 15” in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)2072
Number of pages1
JournalNature Medicine
Volume31
Issue number6
DOIs
StatePublished - Jun 2025

Fingerprint

Dive into the research topics of 'Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial (Nature Medicine, (2025), 31, 6, (1994-2003), 10.1038/s41591-025-03627-5)'. Together they form a unique fingerprint.

Cite this